Here's something you might be interested in.
Medical Marijuana, Inc., a San Diego-based holding company announced today that its Cannabidiol and THC Free product lines will be available in the United States effective August 1. The company filed a patent for its process in extracting the compound from marijuana in May.
Cannabidiol (CBD), one of more than 80 cannabinoids (chemical compounds) individually identified in the cannabis plant, has been shown to relieve convulsion, anxiety, nausea, and inflammation. It has also shown promise in treating schizophrenia and inhibiting cancer cell growth. Because the compound is separated from tetrahydrocannabinol (THC, the psychoactive part of the cannabis plant), it is not included in the Schedule 1 list of federally prohibited drugs.
The substance will be available in CBD tablets, capsules, and infused in beverages. They’ll be available at “more than two thousand health and wellness centers throughout the United States as well as direct to consumers.”
Per the company’s website, “Medical Marijuana Inc. is a publicly traded holding company which invests, develops and owns subsidiaries engaged in a number of diversified international businesses within the Medical Cannabis and Industrial Hemp Industries.” In addition to distributing the stripped cannabinoid, the company has a stake in ‘recommendation clinics’ where many patients seek the doctor’s recommendations they need in order to procure medical marijuana. They’ve also announced plans to petition the DEA for federal permission to cultivate marijuana.
Medical Marijuana, Inc., a San Diego-based holding company announced today that its Cannabidiol and THC Free product lines will be available in the United States effective August 1. The company filed a patent for its process in extracting the compound from marijuana in May.
Cannabidiol (CBD), one of more than 80 cannabinoids (chemical compounds) individually identified in the cannabis plant, has been shown to relieve convulsion, anxiety, nausea, and inflammation. It has also shown promise in treating schizophrenia and inhibiting cancer cell growth. Because the compound is separated from tetrahydrocannabinol (THC, the psychoactive part of the cannabis plant), it is not included in the Schedule 1 list of federally prohibited drugs.
The substance will be available in CBD tablets, capsules, and infused in beverages. They’ll be available at “more than two thousand health and wellness centers throughout the United States as well as direct to consumers.”
Per the company’s website, “Medical Marijuana Inc. is a publicly traded holding company which invests, develops and owns subsidiaries engaged in a number of diversified international businesses within the Medical Cannabis and Industrial Hemp Industries.” In addition to distributing the stripped cannabinoid, the company has a stake in ‘recommendation clinics’ where many patients seek the doctor’s recommendations they need in order to procure medical marijuana. They’ve also announced plans to petition the DEA for federal permission to cultivate marijuana.